Daytona Street Capital’s Elevance Health ELV Stock Holding History

Daytona Street Capital’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$417K	Hold	1,000	–	–	0.3%	71
2026 Q1	$297K	Buy	+1,000	New	+$329K	0.23%	88

Other funds holding ELV

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AACR

ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return

HGIM

High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Daytona Street Capital's ELV Position: Q2 2026 in Review

Daytona Street Capital held its Elevance Health (ELV) position steady in Q2 2026 at 1,000 shares worth $417K. The position accounts for 0.3% of the portfolio, ranked #71.

Daytona Street Capital first reported a position in ELV in Q1 2026 and has held it in 2 quarters since. 858 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Daytona Street Capital held 1,000 shares of Elevance Health worth $417K as of Q2 2026.
Daytona Street Capital left its Elevance Health share count unchanged in Q2 2026.
Elevance Health made up 0.3% of Daytona Street Capital's portfolio in Q2 2026, its #71 holding.
Daytona Street Capital first reported a position in Elevance Health in Q1 2026 and has held it in 2 quarters since.
858 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Daytona Street Capital's 13F filing for Q2 2026, filed 3 Aug 2026.